Basic Information
LncRNA/CircRNA Name | MIR205HG |
Synonyms | NA |
Region | GRCh38_1:209428820-209432838 |
Ensemble | ENSG00000230937 |
Refseq | NR_145433 |
Classification Information
Regulatory Mechanism | Biological Function | Clinical Application | |||
---|---|---|---|---|---|
TF | Immune | Survival | |||
Enhancer | Apoptosis | Drug | |||
Variant | Cell Growth | Circulating | |||
MiRNA | EMT | Metastasis | |||
Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
Cancer Name | lung squamous cell carcinoma |
ICD-0-3 | C34 |
Methods | qPCR, Western blot etc |
Sample | lung squamous cell carcinoma tissues, cell lines(16HBE, BEAS-2B, EPLC-32M1, and NCI-H520) |
Expression Pattern | up-regulated |
Function Description | Importantly, MIR205HG was upregulated in LUSC clinical samples as well as in LUSC cell lines. Interestingly, our results demonstrated that the expression level of MIR205HG is positively correlated with the malignancy. In addition, MIR205HG is required for LUSC cell growth and cell migration. Most importantly, our results showed that MIR205HG prohibits LUSC apoptosis via regulating Bcl-2 and Bax. |
Pubmed ID | 32188965 |
Year | 2020 |
Title | MIR205HG Facilitates Carcinogenesis of Lung Squamous Cell Carcinoma in Vitro Revealed by Long Noncoding RNA Profiling |
External Links
Links for MIR205HG | GenBank HGNC NONCODE |
Links for lung squamous cell carcinoma | OMIM COSMIC |